Teva Branded Pharmaceutical Products R&D, Inc.

Quick facts

Marketed products

• ABS · Cardiovascular
  Acetylsalicylic acid acts as a non-selective COX inhibitor, reducing inflammation and platelet aggregation.
• Albuterol eMDPI DS · Respiratory
  Albuterol is a beta-2 adrenergic agonist that stimulates beta-2 receptors on airway smooth muscle to cause bronchodilation and improve airflow.
• Albuterol-HFA-BAI
• Albuterol-HFA-MDI · Respiratory
  Albuterol is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing relaxation and bronchodilation.
• Depo-subQ Provera · Contraception; Women's Health
  Depo-subQ Provera is a progestin that suppresses the luteinizing hormone surge, preventing ovulation and providing contraceptive efficacy.
• desogestrel/ethinyl estradiol · Contraception / Gynecology
  Desogestrel/ethinyl estradiol is a combined oral contraceptive that prevents pregnancy by suppressing ovulation through progestin and estrogen activity.
• FLOVENT HFA
• Fludeoxyglucose F 18 (FDG) · Oncology; Neurology; Cardiology
  Fludeoxyglucose F-18 is a glucose analog labeled with fluorine-18 that accumulates in tissues with high metabolic activity, enabling detection via positron emission tomography (PET) imaging.
• Glatiramer acetate (GA) · Immunology; Neurology
  Glatiramer acetate is a synthetic polypeptide that modulates immune responses by promoting the differentiation of T cells toward anti-inflammatory phenotypes and reducing autoreactive T cell responses in multiple sclerosis.
• Kariva® · Contraception / Gynecology
  Kariva is an oral contraceptive that prevents pregnancy by suppressing ovulation through a combination of ethinyl estradiol and desogestrel.
• Oral Corticosteroid (OCS) · Immunology
  Oral corticosteroids suppress the immune system and reduce inflammation by binding to glucocorticoid receptors in the cytoplasm and modulating gene transcription.
• ProAir® HFA · Respiratory / Pulmonology
  ProAir HFA is a short-acting beta-2 adrenergic agonist that relaxes airway smooth muscle to rapidly relieve bronchospasm and improve airflow in the lungs.
• Proventil® HFA · Respiratory / Pulmonology
  Proventil HFA is a short-acting beta-2 adrenergic agonist that relaxes airway smooth muscle to rapidly relieve bronchospasm and improve airflow.
• Qvar · Respiratory/Pulmonology
  Qvar is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue.
• Servent Diskus · Respiratory / Pulmonology
  Salmeterol is a long-acting beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing bronchodilation and improved airflow.
• Standard of Care Asthma Medication · Respiratory/Pulmonology
  Standard of care asthma medications typically work by reducing airway inflammation and/or dilating airways to improve breathing.
• Standard of Care Rescue Medication
  Standard of Care Rescue Medication refers to an established, approved therapeutic agent used as a backup treatment when primary therapies fail or are contraindicated.

Phase 3 pipeline

• ACR16
  ACR16 is an investigational therapeutic in phase 3 development by Teva, but its specific mechanism of action is not publicly disclosed.
• albuterol aerosol by HFA BOI · Respiratory
  Albuterol works by stimulating the beta-2 receptors in the lungs, causing bronchodilation and relaxation of bronchial smooth muscle.
• albuterol aerosol by HFA MDI · Respiratory
  Albuterol works by stimulating the beta-2 adrenergic receptors in the lungs, causing bronchodilation and relaxation of bronchial smooth muscle.
• Albuterol MDPI · Respiratory
  Albuterol is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing relaxation and bronchodilation.
• albuterol/salbutamol HFA · Respiratory
  Albuterol/salbutamol HFA is a short-acting beta-2 adrenergic receptor agonist that works by relaxing bronchial muscles to improve airflow to the lungs.
• Albuterol/salmeterol HFA MDI · Respiratory/Pulmonology
  Albuterol and salmeterol are beta-2 adrenergic agonists that relax airway smooth muscle to improve breathing, with albuterol providing rapid relief and salmeterol offering sustained bronchodilation.
• Albuterol sulfate (ABS) · Respiratory
  Albuterol sulfate is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing relaxation and bronchodilation.
• BDP · Respiratory / Pulmonology
  BDP is a inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs.
• BDP HFA · Respiratory / Pulmonology
  BDP HFA is a inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs.
• BDP Nasal Aerosol · Respiratory / Allergy
  BDP (beclomethasone dipropionate) is a corticosteroid that reduces inflammation in the nasal airways by suppressing immune responses and decreasing inflammatory mediator release.
• Beclomethasone Dipropionate 640 · Respiratory
  Beclomethasone dipropionate is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in the lungs.
• Beclomethasone dipropionate BAI · Respiratory / Immunology
  Beclomethasone dipropionate is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in target tissues.
• Beclomethasone dipropionate breath-actuated inhaler · Respiratory/Pulmonology
  Beclomethasone dipropionate is a corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator release.
• Beclomethasone dipropionate MDI · Respiratory / Pulmonology
  Beclomethasone dipropionate is a corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator release.
• Budesonide/Formoterol SPIROMAX® · Respiratory/Pulmonology
  Budesonide/Formoterol combines an inhaled corticosteroid that reduces airway inflammation with a long-acting beta-2 agonist that relaxes airway smooth muscle.
• DR-102 · Rheumatology
  DR-102 is a small molecule that inhibits the activity of a specific enzyme.
• Experimental Glatiramer Acetate
• Fp/ABS · Unknown
  Fp/ABS is a medication that works by inhibiting the action of a specific enzyme.
• Fp MDPI · Immunology
  Fp MDPI is a small molecule that targets the sphingosine-1-phosphate receptor 1 (S1PR1) to modulate immune cell trafficking.
• FS MDPI · Psychiatry/Neurology
  FS MDPI is a monoamine oxidase inhibitor that increases levels of dopamine, norepinephrine, and serotonin in the central nervous system.
• Glatiramer Acetate (DB) · Immunology; Neurology
  Glatiramer acetate is a synthetic polypeptide that modulates immune responses by promoting the differentiation of T cells toward anti-inflammatory phenotypes, reducing attacks on myelin in the central nervous system.
• Glatiramer Acetate (OL) · Immunology; Neurology
  Glatiramer acetate is a synthetic polypeptide that modulates immune responses by promoting anti-inflammatory T cell and B cell responses against myelin antigens.
• Hydrocodone ER · Pain Management
  Hydrocodone is an opioid agonist that binds to mu-opioid receptors in the central nervous system to reduce pain perception and provide analgesia.
• Mircette® · Contraception / Gynecology
  Mircette is a combined oral contraceptive that prevents pregnancy by suppressing ovulation through progestin and estrogen hormones.
• Neugranin · Other
• placebo aerosol by HFA
  This drug is a placebo aerosol by HFA, which does not have a pharmacological effect.
• Placebo BAI
  Placebo BAI is an inert substance with no active pharmacological mechanism.
• Placebo breath-actuated inhaler
  A placebo inhaler device that delivers no active pharmaceutical ingredient, used as a control comparator in clinical trials.
• Placebo MDPI
  Placebo MDPI is an inert control formulation with no active pharmacological mechanism.
• Placebo Nasal Aerosol
  A placebo nasal aerosol contains no active pharmaceutical ingredient and produces therapeutic effects through the placebo effect.
• Prednisone capsules · Immunology / Rheumatology / General anti-inflammatory
  Prednisone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors in cells.
• TEV-56248 · Neurology
  TEV-56248 is a small molecule drug that acts as a selective inhibitor of the sodium-activated potassium channel, KCNN4.
• TV-46000 · Cardiovascular
  TV-46000 is a small molecule in development for the treatment of atrial fibrillation.
• TV-46763 · Diabetes
  TV-46763 is a small molecule drug that targets the SGLT2 receptor.

Phase 2 pipeline

• ADASUVE® · Psychiatry / Behavioral Health
  ADASUVE is a loxapine inhalation powder that blocks dopamine receptors in the brain to rapidly reduce agitation.
• Albuterol HFA-BOI · Respiratory
  Albuterol is a beta-2 adrenergic agonist that stimulates beta-2 receptors on airway smooth muscle to cause bronchodilation and improve airflow.
• Beclomethasone dipropionate HFA Nasal Aerosol · Respiratory
  Beclomethasone dipropionate is a corticosteroid that binds to glucocorticoid receptors, reducing inflammation and immune responses in the nasal passages.
• Bronchodilator · Respiratory
• Glatiramer Acetate, N-Acetylcysteine
• glatiramer acetate with minocycline
• Group R Rasagiline
• laquinimod 0.3
• LBR-101 High Dose
• LBR-101 Low Dose
• Nebulized IVX-0142
• TEV-56286
• TP-38
• TP38
• TV-45070

Phase 1 pipeline

• [14C]-TEV-56286
• Albuterol dry powder inhaler
• BDP HFA Nasal Aerosol
• CEP-26401
• Fluticasone Propionate MDPI
• LBR-101 IV
• LBR-101 SC
• Reslizumab IV
• Reslizumab SC
• TEV-48125 - 1
• TEV-48125 - 2
• TEV-48125 - 3
• TEV-56278
• TL011
• TV-46046

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Teva Branded Pharmaceutical Products R&D, Inc. portfolio CI brief
• Teva Branded Pharmaceutical Products R&D, Inc. pipeline updates RSS